Integra Lifesciences Holdings (IART) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Integra Lifesciences Holdings · Health Care · ref. ETF XLV · 51 calls · price $13.85
What the company does: Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
📈 Integra Lifesciences Holdings (IART) stock price
$13.85-3.8% over range
Oct 14, 25low $8.9 · high $19.85Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 5 analysts
📊 JPI status : Integra Lifesciences Holdings has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 IART price target & analyst consensus — price $13.85
The price target · all analysts combined (5 targets)
Highest target · 2 firms of 5$19+37.2%
Median target · of 5 targets$18+30.0%
Lowest target · 2 firms of 5$15+8.3%
Current price$13.85
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
5100%
$15 ↔ $19
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $19 (+37 %), call made on July 29, 2026, maturing on July 29, 2027 (77 d ago).
The 1 reliable analyst
$19+37 %
The 4 other firms
$16.50+19 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $19 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold5100%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 IART price target all
All 51 calls, one by one, with our verdict on each firm.
→ See all 51 targets, analyst by analyst💡 The best analysts on IART most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in IART? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Integra Lifesciences Holdings? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on IART
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +49.1% | 2 |
| Citigroup ↗ | 100% | +31.9% | 7 |
| Oppenheimer ↗ | 100% | +29.0% | 4 |
| BTIG ↗ | 100% | +27.0% | 3 |
| Raymond James ↗ | 100% | +25.9% | 2 |
| Lake Street | 100% | +22.9% | 2 |
| Piper Sandler ↗ | 100% | +18.4% | 2 |
| Morgan Stanley ↗ | 80% | +38.3% | 5 |
| Credit Suisse | 75% | +17.2% | 8 |
| B of A Securities ↗ | 67% | +15.8% | 6 |
See the other 5 firms
| JMP Securities | 36% | -18.8% | 14 |
| Argus Research ↗ | 50% | -21.5% | 2 |
| Wells Fargo ↗ | 50% | -10.4% | 2 |
| JP Morgan ↗ | 60% | +10.8% | 5 |
| Jefferies ↗ | 67% | +1.9% | 6 |
📊 What $1,000 invested in Integra Lifesciences Holdings would be worth › open the full page
In short — $1,000 invested in Integra Lifesciences Holdings 10 years ago would be worth $543 today, i.e. -6%/yr on average. Best year: 2019 (+29%), worst: 2024 (-48%). Price performance, excluding dividends.
If I'd invested $1,000 in Integra Lifesciences Holdings
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $811 | -19% |
| 3 years ago | $328 | -67% |
| 5 years ago | $283 | -72% |
Return by year (Integra Lifesciences Holdings)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +48% | $1,481 (+48%) |
| 2025 | -45% | $811 (-19%) |
| 2024 | -48% | $423 (-58%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Integra Lifesciences Holdings
Loading news…
📋 All analyst calls on IART
Filtered on — · ✕ show all
■ Neutral neutral · not a buy · 🎯$15
Price at call : $13.32 — gap to target +13%
Today : $13.85 — gap to target +8%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Oct 5, 27
matures : Oct 5, 27
BMO Capital ↗
Oct 5, 26
■ Market Perform neutral · not a buy · 🎯$15
Price at call : $13.29 — gap to target +13%
Today : $13.85 — gap to target +8%
🎯 on IART : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Oct 5, 27
matures : Oct 5, 27
Wells Fargo ↗
Jul 30, 26
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $16.65 — gap to target +8%
Today : $13.85 — gap to target +30%
🎯 on IART : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Neutral neutral · not a buy · 🎯$19
Price at call : $16.49 — gap to target +15%
Today : $13.85 — gap to target +37%
🎯 on IART : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
Truist Securities ↗
Jul 16, 26
■ Hold neutral · not a buy · 🎯$19
Price at call : $19.25 — gap to target -1%
Today : $13.85 — gap to target +37%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$19
Price at call : $18.79 — gap to target +1%
Today : $13.85 — gap to target +37%
🎯 on IART : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
■ Neutral neutral · not a buy · 🎯$19
Price at call : $18.39 — gap to target +3%
Today : $13.85 — gap to target +37%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
■ Neutral neutral · not a buy · 🎯$16
Price at call : $16.04 — gap to target -0%
Today : $13.85 — gap to target +16%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
See the other 43 calls, newest to oldest
▼ Sell · 🎯$11
Price at call : $13.56 — upside -19%
Today : $13.85 — upside -21%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Wells Fargo ↗
May 6, 26
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $13.56 — gap to target +11%
Today : $13.85 — gap to target +8%
🎯 on IART : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Truist Securities ↗
Apr 15, 26
■ Hold neutral · not a buy · 🎯$12
Price at call : $10.84 — gap to target +11%
Today : $13.85 — gap to target -13%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Argus Research ↗
Apr 15, 26
■ Hold neutral · not a buy
🎯 on IART : 0% (1 call matured) · 📊 on Health : 18.2% · -27.9% (11 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▼ Sell · 🎯$9
Price at call : $9.17 — upside -2%
Today : $13.85 — upside -35%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
Wells Fargo ↗
Feb 27, 26
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $10.43 — gap to target +15%
Today : $13.85 — gap to target -13%
🎯 on IART : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
Truist Securities ↗
Nov 3, 25
■ Hold neutral · not a buy · 🎯$13
Price at call : $11.3 — gap to target +15%
Today : $13.85 — gap to target -6%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
▼ Sell · 🎯$11
Price at call : $11.49 — upside -4%
Today : $13.85 — upside -21%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
▼ Underweight · 🎯$13
Price at call : $11.49 — upside +13%
Today : $13.85 — upside -6%
🎯 on IART : 0% (1 call matured) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Truist Securities ↗
Oct 15, 25
■ Hold neutral · not a buy · 🎯$15
Price at call : $14.61 — gap to target +3%
Today : $13.85 — gap to target +8%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
▼ Sell · 🎯$12
Price at call : $14.81 — upside -19%
Today : $13.85 — upside -13%
Expected -19% · Actual -9% · Reason (≤ −15%) : ✗ No
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
+9.4%
stock -9% · XLV +16%
matured Oct 7, 26
JMP Securities
May 9, 25
▲ Market Outperform · 🎯$25
Price at call : $13.67 — upside +83%
Today : $13.85 — upside +81%
Expected +83% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on IART : 25% (4 calls matureds) · 📊 unranked overall
+2.2%
stock +2% · XLV +5%
matured May 9, 26
▼ Underweight · 🎯$12
Price at call : $12.73 — upside -6%
Today : $13.85 — upside -13%
Expected -6% · Actual +7% · Reason (≤ −15%) : ✗ No
🎯 on IART : 0% (1 call matured) · 📊 on Health : 49% · +6.7% (149 calls)
-6.5%
stock +7% · XLV +7%
matured May 6, 26
Wells Fargo ↗
May 6, 25
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $12.75 — gap to target +2%
Today : $13.85 — gap to target -6%
🎯 on IART : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : May 6, 26
matures : May 6, 26
Truist Securities ↗
Apr 11, 25
■ Hold neutral · not a buy · 🎯$19
Price at call : $16.99 — gap to target +12%
Today : $13.85 — gap to target +37%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Apr 11, 26
matures : Apr 11, 26
Argus Research ↗
Mar 31, 25
▲ Buy
Actual -56% · Reason (≥ +15%) : ✗ No
🎯 on IART : 0% (1 call matured) · 📊 on Health : 18.2% · -27.9% (11 calls)
-55.7%
stock -56% · XLV +3%
matured Mar 31, 26
Citizens Capital Markets
Feb 26, 25
▲ Market Outperform · 🎯$35
Price at call : $23.06 — upside +52%
Today : $13.85 — upside +153%
Expected +52% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on IART : 0% (1 call matured) · 📊 unranked overall
-50.6%
stock -51% · XLV +9%
matured Feb 26, 26
▼ Sell · 🎯$22
Price at call : $26.7 — upside -18%
Today : $13.85 — upside +59%
Expected -18% · Actual -58% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
+58.0%
stock -58% · XLV -1%
matured Nov 5, 25
Truist Securities ↗
Oct 14, 24
■ Hold neutral · not a buy · 🎯$21
Price at call : $19.51 — gap to target +8%
Today : $13.85 — gap to target +52%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Oct 14, 25
matures : Oct 14, 25
B of A Securities ↗
Oct 7, 24
▼ Underperform · 🎯$18
Price at call : $17.49 — upside +3%
Today : $13.85 — upside +30%
Expected +3% · Actual -15% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 51.9% · +3.9% (156 calls)
+15.3%
stock -15% · XLV -5%
matured Oct 7, 25
■ Neutral neutral · not a buy
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Oct 7, 25
matures : Oct 7, 25
▼ Sell · 🎯$16
Price at call : $17.32 — upside -8%
Today : $13.85 — upside +16%
Expected -8% · Actual -19% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
+19.3%
stock -19% · XLV -6%
matured Oct 1, 25
▼ Sell · 🎯$20
Price at call : $20.71 — upside -3%
Today : $13.85 — upside +44%
Expected -3% · Actual -27% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+26.9%
stock -27% · XLV -12%
matured Aug 28, 25
▼ Sell · 🎯$20
Price at call : $21.07 — upside -5%
Today : $13.85 — upside +44%
Expected -5% · Actual -32% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
+32.3%
stock -32% · XLV -12%
matured Aug 22, 25
JMP Securities
Jul 30, 24
▲ Market Outperform · 🎯$35
Price at call : $24.81 — upside +41%
Today : $13.85 — upside +153%
Expected +41% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on IART : 25% (4 calls matureds) · 📊 unranked overall
-47.0%
stock -47% · XLV -13%
matured Jul 30, 25
Truist Securities ↗
Jul 30, 24
■ Hold neutral · not a buy · 🎯$26
Price at call : $25.03 — gap to target +4%
Today : $13.85 — gap to target +88%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 30, 25
matures : Jul 30, 25
▼ Sell · 🎯$23
Price at call : $25.03 — upside -8%
Today : $13.85 — upside +66%
Expected -8% · Actual -51% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
+50.6%
stock -51% · XLV -11%
matured Jul 30, 25
▼ Sell · 🎯$22
Price at call : $25.03 — upside -12%
Today : $13.85 — upside +59%
Expected -12% · Actual -51% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+50.6%
stock -51% · XLV -11%
matured Jul 30, 25
Truist Securities ↗
Jul 16, 24
■ Hold neutral · not a buy · 🎯$32
Price at call : $31.65 — gap to target +1%
Today : $13.85 — gap to target +131%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 16, 25
matures : Jul 16, 25
Morgan Stanley ↗
Jul 15, 24
▼ Underweight · 🎯$27
Price at call : $31.74 — upside -15%
Today : $13.85 — upside +95%
Expected -15% · Actual -62% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+61.9%
stock -62% · XLV -10%
matured Jul 15, 25
■ Neutral neutral · not a buy · 🎯$30
Price at call : $30.61 — gap to target -2%
Today : $13.85 — gap to target +117%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jul 11, 25
matures : Jul 11, 25
■ Neutral neutral · not a buy · 🎯$28
Price at call : $28.51 — gap to target -2%
Today : $13.85 — gap to target +102%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : May 22, 25
matures : May 22, 25
Morgan Stanley ↗
May 7, 24
▼ Underweight · 🎯$24
Price at call : $24.91 — upside -4%
Today : $13.85 — upside +73%
Expected -4% · Actual -48% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+48.3%
stock -48% · XLV -6%
matured May 7, 25
JMP Securities
May 7, 24
▲ Market Outperform · 🎯$40
Price at call : $24.91 — upside +61%
Today : $13.85 — upside +189%
Expected +61% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on IART : 25% (4 calls matureds) · 📊 unranked overall
-48.3%
stock -48% · XLV -6%
matured May 7, 25
Wells Fargo ↗
May 7, 24
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $25.08 — gap to target -0%
Today : $13.85 — gap to target +81%
🎯 on IART : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : May 7, 25
matures : May 7, 25
Truist Securities ↗
May 7, 24
■ Hold neutral · not a buy · 🎯$25
Price at call : $25.08 — gap to target -0%
Today : $13.85 — gap to target +81%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : May 7, 25
matures : May 7, 25
B of A Securities ↗
May 7, 24
▼ Underperform · 🎯$26
Price at call : $25.08 — upside +4%
Today : $13.85 — upside +88%
Expected +4% · Actual -49% · Reason (≤ −15%) : ✓ Yes
🎯 on IART : 100% (2 calls matureds) · 📊 on Health : 51.9% · +3.9% (156 calls)
+49.2%
stock -49% · XLV -5%
matured May 7, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $33.8 — gap to target +12%
Today : $13.85 — gap to target +174%
🎯 on IART : 100% (5 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Apr 3, 25
matures : Apr 3, 25
Truist Securities ↗
Mar 1, 24
■ Hold neutral · not a buy · 🎯$41
Price at call : $35.99 — gap to target +14%
Today : $13.85 — gap to target +196%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Mar 1, 25
matures : Mar 1, 25
JMP Securities
Feb 29, 24
▲ Market Outperform · 🎯$49
Price at call : $35.99 — upside +36%
Today : $13.85 — upside +254%
Expected +36% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on IART : 25% (4 calls matureds) · 📊 unranked overall
-37.5%
stock -38% · XLV +2%
matured Feb 28, 25
Truist Securities ↗
Dec 22, 23
■ Hold neutral · not a buy · 🎯$46
Price at call : $44.38 — gap to target +4%
Today : $13.85 — gap to target +232%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Dec 21, 24
matures : Dec 21, 24
Truist Securities ↗
Dec 14, 23
■ Hold neutral · not a buy · 🎯$44
Price at call : $42.77 — gap to target +3%
Today : $13.85 — gap to target +218%
🎯 on IART : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Dec 13, 24
matures : Dec 13, 24
Argus Research ↗
Jun 8, 23
■ Hold neutral · not a buy
🎯 on IART : 0% (1 call matured) · 📊 on Health : 18.2% · -27.9% (11 calls)
in progress (365j)
matures : Jun 7, 24
matures : Jun 7, 24
Frequently asked questions
Should I buy Integra Lifesciences Holdings stock?
This isn't buy advice. For Integra Lifesciences Holdings, the analyst consensus is "Hold", with an average price target of $18.00 (+30% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Integra Lifesciences Holdings). We show the numbers — you decide.
Is it too late to buy Integra Lifesciences Holdings? How high can it go?
The most bullish analyst target on Integra Lifesciences Holdings is $19.00 (+37% above today's price); the average is $18.00. That's the upside they see. Check how reliable those analysts have actually been on Integra Lifesciences Holdings on our site before trusting it.
Is Integra Lifesciences Holdings still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 15 analysts have a real record on Integra Lifesciences Holdings, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Integra Lifesciences Holdings? The case for and against
The arguments for and against, one by one, from the numbers: why invest in IART (and why hesitate).
What has Integra Lifesciences Holdings's past performance been?
Historical returns and a "how much if I had invested" calculator: IART performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX